About
- Why Us
- Our Leadership
PayerPro360
Competitive Intelligence
Forecasting
Report Library
Media

Posted on 2021-05-27 in Insights

Pipeline Checkpoint Inhibitors Targeting LAG-3

Thelansis report library mini banner

Follow Us On

Latest Newsletters

FDA Grants Fast Track Designation to MorphoSys AG’s Promising Endometrial Cancer Treatment
CyGenica Receives Orphan Drug Designation for Glioblastoma Multiforme (GBM) Treatment
Healx Secures FDA Orphan Drug Designation for AI-Discovered NF1 Treatment – HLX-1502 Unveiled!
INOVIO’s INO-3107 Granted FDA Breakthrough Therapy Designation for RRP Treatment
Avenge Bio’s AVB-001 Granted FDA Orphan Drug Designation for Mesothelioma Treatment

You May Also Like:

Major development efforts are focused on rare and oncology indications

Major development efforts are focused on rare and oncology indications

USA PD 1 Utilization in Advance and Metastatic Renal Cell Carcinoma-2022

USA: PD 1 Utilization in Advance and Metastatic Renal Cell Carcinoma-2022

USA PD 1 Utilization in Advanced and Metastatic Melanoma - 2022

USA: PD 1 Utilization in Advanced and Metastatic Melanoma – 2022

Share This Article

Post navigation

PreviousCrohn’s Disease (CD) – Press Release

NextBridgeBio Pharma announced FDA granted approval to Truseltiq for advanced Cholangiocarcinoma

Copyright ©2024 THELANSIS. All rights reserved.

Filters

PayerPro360 Demo Request

Fill in your details and our expert consultants will get in touch with you.

Name *

Company Name *

Email *

Phone No. *

Job Title

Interest Area

Comment/Question

Phone

Pankaj Negi

Head – Business Development and Partnering

Mr. Pankaj Negi has joined Thelansis as Practice Head; Business Development and Partnering, since Jan 2020. A dynamic professional with 12+ years of diverse experience across Pharmaceuticals/ Healthcare/ Life sciences with specialized in sales & marketing and Business Development.

Mr. Pankaj is holding a Master’s degree in “Pharma Management” from the Rajiv Gandhi University of Health Science, Bangalore, India and has expertise in Content Marketing, Content Management systems, Customer Relationship Management, online marketing, advertising, promotion, and Search Engine Optimization. Creating and implementing client-centered, successful campaigns, aimed at improving brand awareness and presence.

Username or E-mail*

Password*

Only fill in if you are not human

Keep me signed in

Forgot your password?

Mukesh Kumar

Vice President – Delivery, Scientific CI

Mukesh Kumar has joined us as Vice President – Delivery & Innovations, Scientific CI Practice, since August 2019. Prior to joining us, Dr. Mukesh holding a Postdoctoral Fellow with a demonstrated history of working in hard-core research for more than 15 years on both small molecule and biologics within the oncology and neurology segment.

Skilled in Recombinant DNA, Phage Display Technology, Antibodies, ImmunoOncology (K-RAS, Check-Point, Oncolytic), and Immunotherapeutic (RNA andProtein/huMab-based) products, Cancer-stem Cells, Chemoresistance, Real-TimePolymerase Chain Reaction (qPCR), and SDS-PAGE. Strong research professional with a Ph.D. focused on Recombinant Antibody-mediated tumor targeting. Dr.Mukesh has several citations on Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis, Membrane, Fusion Mediated Targeted Cytosolic DrugDelivery Through scFv Engineered Sendai Viral Envelopes, and Drug combination targeting hypoxia-induced chemoresistance and stemness in glioma cells.

Peeyush Potdar

Director – Practice Head, Competitive Intelligence, Market Access, and Pricing

Mr. Peeyush Potdar is working at Thelansis as Practice Head; Competitive Intelligence, Market Access, and Pricing Analytics, since Dec 2017. With 12+ years of rich experience in providing business consulting and research support across competitive intelligence, BD&L activities, KOL management, business research, and analytics services, he has been involved in the development of syndicated therapy area specialized reports in Orphan & ultra-orphan indications and conducting market intelligence assignments on different verticals such as Pharmaceuticals, Medical Devices and Health Insurance.

Mr. Peeyush is holding an MBA degree in “Pharma Management” from the National Institute of Pharmaceutical Education & Research (NIPER), Mohali, India and has expertise in scientific research as well as in commercialization and lifecycle management for innovative and mature assets. He has a good competency in building AI/ ML-based analytics platforms for tracking global conferences, social media analytics, and for conducting patient outcomes research.

Martina Berg

Director – Global Relationship and Partnering US

Ms. Martina is working with us as Director – Global Relationship and Partnering US, since October 2019. Prior to joining us, Ms. Martina holding a Master’s Degree in Public Health from Boston University School of Public Health with more than 8 years of experience in B2B and B2C sales. Highly motivated and accomplished sales and marketing professional with a proven history of success in creating the road map and driving business development globally.

Part of US Leadership team and heading Business Development for Thelansis Knowledge Partner for both US and EU Region. Business Development opportunity identification, Engaging with the client and providing them with innovative business solutions.

Manohar Vashisht

Director – Global Relationship and Partnering EU

Request For Information

Fill in your details and our expert consultants will get in touch with you.

Name *

Company Name *

Email *

Phone No. *

Phone

Search for: